Terms: = Lymphoma AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
155 results:
1. Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren's syndrome: a comparative study.
Bodakçi E
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1760-1767. PubMed ID: 38497858
[TBL] [Abstract] [Full Text] [Related]
2. A rare case of cutaneous lupus erythematosus presenting with periorbital erythema and edema.
Hacınecipoğlu F; Çevirgen Cemil B; Kartal SP; Arslankoz S
Lupus; 2024 Feb; 33(2):183-186. PubMed ID: 38148123
[TBL] [Abstract] [Full Text] [Related]
3. Mycosis fungoides with spongiosis: a case report.
Kashabano JJ; Rugengamazi E; Matiku SB; Mruma RM; Lugina EL
J Med Case Rep; 2023 Nov; 17(1):458. PubMed ID: 37919795
[TBL] [Abstract] [Full Text] [Related]
4. Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights.
Tang IYK; Ho CTK; Li TWL; Li PH
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37902361
[TBL] [Abstract] [Full Text] [Related]
5. [Salivary gland ultrasound or biopsy? : Comparison of methods based on case examples].
Peters J; Timme-Bronsert S; Voll RE; Finzel S
Z Rheumatol; 2023 Oct; 82(8):654-665. PubMed ID: 37782326
[TBL] [Abstract] [Full Text] [Related]
6. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
Mallon B; Kaboré R; Couitchere L; Akonde FB; Narison MLR; Budiongo A; Dackono TA; Pondy A; Diedhiou F; Patte C; Steliarova-Foucher E; Clavel J
Pediatr Blood Cancer; 2023 Dec; 70(12):e30664. PubMed ID: 37732944
[TBL] [Abstract] [Full Text] [Related]
7. Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist?
Baldini C; Berardicurti O; Giacomelli R; Bombardieri M
Autoimmun Rev; 2024 Jan; 23(1):103425. PubMed ID: 37634677
[TBL] [Abstract] [Full Text] [Related]
8. Enhancing information on stage at diagnosis for childhood cancer in Africa.
Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities.
Davies L; Milner DA; Shulman LN; Kyokunda L; Bedada A; Vuylsteke P; Masalu N; Jackson P; Jennings N; Odunlami A; Mtshali P; Dugan U
JCO Glob Oncol; 2023 Jun; 9():e2200203. PubMed ID: 37290022
[TBL] [Abstract] [Full Text] [Related]
10. Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements.
Oh BC; Cho AR; Nam JH; Yang SY; Kim MJ; Kwon SH; Lee EK
BMC Cancer; 2023 May; 23(1):482. PubMed ID: 37248452
[TBL] [Abstract] [Full Text] [Related]
11. Salivary gland ultrasound in clinical practice: What is its real usefulness?
Carpio Astudillo K; Montero Reyes F; Janta I; Molina Collada J; Anzola AM; Caballero Motta LR; Serrano-Benavente B; Martínez-Barrio J; Ariza Lapuente A; Rivera Redondo J; González-Fernández C; Monteagudo I; Álvaro-Gracia JM; Nieto-González JC
Reumatol Clin (Engl Ed); 2023 May; 19(5):260-265. PubMed ID: 37147062
[TBL] [Abstract] [Full Text] [Related]
12. Distinctive Attributes of Indian Patients With Classical BCR::ABL1 Negative Myeloproliferative Neoplasms: Unified Clinical and Laboratory Data.
Singh S; Singh J; Mehta A; Sharma R; Joshi K; Jain K; Paul D; Oberoi G; Jindal N; Dhillon B; Narang V
Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):360-369.e1. PubMed ID: 36849307
[TBL] [Abstract] [Full Text] [Related]
13. [Lymphoplasmacytic lymphoma accompanied by severe myelofibrosis].
Takarada A; Momose H; Kurita N; Matsuoka R; Nakamura N; Sakamoto T; Kato T; Hattori K; Suehara Y; Yokoyama Y; Nishikii H; Maruyama Y; Obara N; Chiba S; Sakata-Yanagimoto M
Rinsho Ketsueki; 2023; 64(1):54-59. PubMed ID: 36775308
[TBL] [Abstract] [Full Text] [Related]
14. The clinical phenotype of primary Sjögren's syndrome patients with lymphadenopathy.
Stergiou IE; Chatzis LG; Pezoulas VC; Baldini C; Fotiadis DI; Voulgarelis M; Tzioufas AG; Goules AV
Clin Exp Rheumatol; 2022 Dec; 40(12):2357-2362. PubMed ID: 36541237
[TBL] [Abstract] [Full Text] [Related]
15. Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjögren's syndrome: A critical review.
Vílchez-Oya F; Balastegui Martin H; García-Martínez E; Corominas H
Front Immunol; 2022; 13():1003054. PubMed ID: 36325321
[TBL] [Abstract] [Full Text] [Related]
16. An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal lymphomas.
Venturutti L; Rivas MA; Pelzer BW; Flümann R; Hansen J; Karagiannidis I; Xia M; McNally DR; Isshiki Y; Lytle A; Teater M; Chin CR; Meydan C; Knittel G; Ricker E; Mason CE; Ye X; Pan-Hammarström Q; Steidl C; Scott DW; Reinhardt HC; Pernis AB; Béguelin W; Melnick AM
Cancer Discov; 2023 Jan; 13(1):216-243. PubMed ID: 36264161
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and laboratory evaluation of sicca complaints: distinctive aspects of primary, secondary and non-Sjogren syndrome.
de Oliveira FR; Motta ACF; Módulo CM; Garcia DM; Chiorini JA; Louzada-Junior P; Rocha EM
Adv Rheumatol; 2022 Jul; 62(1):23. PubMed ID: 35778768
[TBL] [Abstract] [Full Text] [Related]
18. Sex hormones, body mass index, and related comorbidities associated with developing Sjögren's disease: a nested case-control study.
McCoy SS; Hetzel S; VanWormer JJ; Bartels CM
Clin Rheumatol; 2022 Oct; 41(10):3065-3074. PubMed ID: 35701626
[TBL] [Abstract] [Full Text] [Related]
19. Kikuchi-Fujimoto disease in the Eastern Mediterranean zone.
Al Manasra AR; Al-Domaidat H; Aideh MA; Al Qaoud D; Al Shalakhti M; Al Khatib S; Fataftah J; Al-Taher R; Nofal M
Sci Rep; 2022 Feb; 12(1):2703. PubMed ID: 35177750
[TBL] [Abstract] [Full Text] [Related]
20. Palliative Care Services within a Pediatric Hematology-Oncology Program in a Low-Resource Setting.
Silverstein A; Butia M; Bank R; Manda G; Nyasulu C; Mwango N; Makuti S; Chikasema M; Torrey S; Hesselgrave J; Casas J; Thambo L; Msekandiana A; Chiume M; Ozuah N; Huibers MH
J Pain Symptom Manage; 2022 May; 63(5):e473-e480. PubMed ID: 35031502
[TBL] [Abstract] [Full Text] [Related]
[Next]
